Orthocell’s Company-led strategic placement has been reported in The West Australian newspaper today, in an article by Senior Business Report Sean Smith titled “Chris Ellison, Rod Jones and the McCuskers jump into Orthocell”.
Here’s an excerpt:
“With Orthocell already sitting on $19.3m in cash, the placement proceeds were not essential. However, the company saw an opportunity to beef up its register to support its global expansion strategy.
“The support of these strategic investors is an endorsement of Orthocell’s science, business strategy and progress in commercialising it’s leading bone and nerve repair products,” chair John Van Der Wielen said.”